Indivior PLC (LSE:INDV) - Share price - Overview

Stock Report

Indivior PLC INDV

Last Price
GBX470.20

Day Change
0.60|0.13%

As of 22/05/2018
08:50:11 BST | GBX
Minimum 15 Minutes Delay.

Last Close469.60p
Day Range468.94 - 472.50
Mkt Cap3.33Bil
52-Wk Range246.50 - 478.20
Yield %0.00
ISINGB00BRS65X63
Volume91,457
P/E4,949.47
P/S3.22
P/CF11.93

Share Price

Total Returns 21/05/2018

 Chg (%)  
More ...
Indivior PLC7.61 
FTSE 100 TR GBP7.00
 
Financials
201520162017
More ...
Income Statement
Turnover1,014.001,058.001,093.00
Operating Profit346.00149.00193.00
Net Profit228.0035.0058.00
Reported EPS0.310.050.08
Balance Sheet
Current Assets721.00990.001,225.00
Non Current Assets216.00219.00219.00
Total Assets937.001,209.001,444.00
Current Liabilities603.001,030.00854.00
Total Liabilities1,216.001,504.001,647.00
Total Equity-279.00-295.00-203.00
Cash Flow
Operating Cash Flow451.00470.00328.00
Net Change in Cash145.00225.00168.00
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
12/03/2018Transfer inMr. Shaun Thaxter0.001,219,4320.00
12/03/2018SaleMr. Shaun Thaxter403.64551,8962,227,684.00
27/02/2018SaleMark Crossley379.00130,501494,599.00
26/02/2018Transfer inMark Crossley0.00288,3450.00

Company Profile

Indivior PLC is a US-based specialty and generic drug manufacturin eneric drug manufacturg company. The firm develops, manufactures, and sells prescription drugs that are mainly based on buprenorphine for treatment of opioid dependence.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Next Event 27/07/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)77.98
Div Yld (E)0.00
PEG (E)0.00
ROCE29.49
Op Mrgn0.18
EPS Grwth0.90
Dividends
PreviousLatest
More ...
Record Date18/09/1517/06/16
Ex-Div17/09/1516/06/16
Paid23/10/1529/07/16
Amnt2.087.30
Directors
More ...
Executive Director, Chief Executive OfficerMr. Shaun Thaxter
Executive Director, Chief Financial OfficerMark Crossley
Non-Executive DirectorMr. Daniel J. Phelan
Non-Executive DirectorMs. Lorna Parker
Non-Executive DirectorMr. Daniel Tasse
Non-Executive DirectorMr. Christian S. Schade
Non-Executive DirectorMs. Lizabeth H. Zlatkus
Non-Executive DirectorDr. Yvonne Greenstreet
Non-Executive Director, ChairmanMr. Howard H. Pien
Non-Executive DirectorMr. A. Thomas McLellan
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.